文献速递认知障碍与痴呆脑血管病

社区人群血脂蛋白水平与新发阿尔茨海默病的关联:弗雷明汉心脏研究

Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study.
PubMed 文献 · Neurology · 2025-05-30

该纵向分析纳入弗雷明汉心脏研究822名60岁及以上无痴呆参与者,检测1985至1988年血脂蛋白水平并随访至2020年。中位随访12.55年期间128人发生阿尔茨海默病。sdLDL-C升高与AD风险增加相关,ApoB48升高与AD风险降低相关,最低HDL-C四分位组AD风险低于其他组。

要点

  • sdLDL-C每升高1个标准差单位,AD风险增加21%(HR 1.21)。
  • ApoB48每升高1个标准差单位,AD风险降低22%(HR 0.78)。
  • 最低HDL-C四分位组较其他组AD风险降低44%(HR 0.56)。

核心结论

  • 较低sdLDL-C和较高ApoB48浓度与较低的阿尔茨海默病风险相关。
  • 最低HDL-C浓度个体较其余样本AD风险更低。
  • 脂蛋白代谢通路与AD风险相关,血脂蛋白标志物可能用于AD风险分层。

研究设计与样本

  • 纵向分析纳入弗雷明汉心脏研究822名60岁及以上无痴呆且具备认知随访和脂蛋白标志物数据的参与者。
  • 血脂蛋白于1985至1988年血样中检测,随访至2020年监测新发AD。
  • AD诊断基于标准临床标准,采用Cox比例风险模型调整基线年龄和性别。

主要发现

  • 中位随访12.55年(IQR 7.34-15)期间128名参与者发生新发AD。
  • ln(sdLDL-C)每增加1个标准差单位,AD风险增加21%(HR 1.21,95%CI 1.01-1.45)。
  • ln(ApoB48)每增加1个标准差单位,AD风险降低22%(HR 0.78,95%CI 0.66-0.93)。
  • 第一HDL-C四分位组较第二、三、四四分位组AD风险降低44%(HR 0.56,95%CI 0.33-0.95)。
  • sdLDL-C低于中位数者较高于中位数者AD风险降低38%(HR 0.62,95%CI 0.44-0.86)。

临床怎么用

  • 对社区老年人可考虑检测sdLDL-C、ApoB48和HDL-C以辅助AD风险分层。
  • 脂质修饰策略可能作为痴呆预防的潜在途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Cardiovascular risk factors are important contributors to the risk of Alzheimer disease (AD). To further explore the physiologic links between cardiovascular health and AD risk, we studied the associations between various blood lipoprotein levels and AD risk in community-dwelling older adults. METHODS: This longitudinal analysis included participants aged 60 years or older without prevalent dementia and with available cognitive follow-up and lipoprotein marker data from the Framingham Heart Study. Levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), small dense LDL-C (sdLDL-C), lipoprotein a (Lp(a)), apolipoprotein B (ApoB), and the ApoB isoform ApoB48 were measured in blood samples obtained from 1985 to 1988. Participants were under surveillance for incident AD until 2020. AD diagnosis was based on standard clinical criteria. The relationships between blood lipoprotein levels (expressed as both continuous variables and quartiles) and AD incidence were examined using Cox proportional hazard models adjusted for baseline age and sex. RESULTS: A total of 822 participants (mean [SD] age 72.5 [3.7] years, 538 [65.5%] women) were followed for a median (interquartile range) of 12.55 (7.34-15) years, during which 128 participants developed incident AD. An increase of 1 standard deviation unit (SDU) in ln(sdLDL-C) concentration was associated with a 21% increase in the risk of incident AD (hazard ratio [HR] 1.21, 95% CI 1.01-1.45), whereas a 1-SDU increase in ln(ApoB48) concentration was associated with a 22% decrease in the risk of incident AD (HR 0.78, 95% CI 0.66-0.93). Participants in the first HDL-C quartile were 44% less likely to develop AD compared with those in the second, third, and fourth HDL-C quartiles (HR 0.56, 95% CI 0.33-0.95). Participants with sdLDL-C concentrations below the median were 38% less likely to develop AD compared with those with sdLDL-C concentrations above the median (HR 0.62, 95% CI 0.44-0.86). DISCUSSION: Lower sdLDL-C and higher ApoB48 concentrations were associated with a lower AD risk. In addition, individuals with the lowest HDL-C concentrations were less likely to develop AD compared with the remaining sample. These findings underscore links between lipoprotein metabolism pathways and AD risk, emphasizing the potential role of blood lipoprotein markers in AD risk stratification and of lipid modification strategies in dementia prevention.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Charisis S, Lu S, Melgarejo JD, et al. Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study. Neurology. 2025. PMID: 40446198. doi:10.1212/WNL.0000000000213715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。